• Search

All Articles

India's termination of BITs to begin

India's termination of BITs to begin

22 March 2017

As its self-imposed 31 March deadline for terminating bilateral investment treaties draws near, India has sent notices of termination to 58 countries that are expected to take effect from as early as next month.

Pakistan to pay in ICSID mining claim

Pakistan to pay in ICSID mining claim

22 March 2017

Pakistan is liable for denying an Australian mining venture a lease for one of its largest copper reserves, an ICSID tribunal hearing a multibillion-dollar claim has ruled – with Pakistani reports indicating that the parties may now settle.

Abu Dhabi fund won’t challenge Citigroup award

Abu Dhabi fund won’t challenge Citigroup award

22 March 2017

A United Arab Emirates sovereign wealth fund that lost a US$2 billion ICDR claim against Citigroup over alleged mismanagement during the 2008 global financial crisis says it does not intend to challenge the now public award.

Multiple cases, one arbitrator

Multiple cases, one arbitrator

22 March 2017

Using common arbitrators for related arbitrations is a regular practice to save time and costs and avoid inconsistent decisions, but challenges to their appointment are becoming increasingly common. Tay Yong Seng of Allen & Gledhill in Singapore seeks to distinguish the baseless objections that can be dismissed quickly from the ones that raise real concerns.

PetroChina submits to arbitration after five-year battle

PetroChina submits to arbitration after five-year battle

22 March 2017

After four years of resistance, PetroChina and five other Chinese state-owned companies have said they will submit to arbitration with a Texas energy investments company in a dispute over oil and gas fields in Chad, potentially ending a five-year row in the US courts.

Chevron stay upheld in LNG jetty dispute

Chevron stay upheld in LNG jetty dispute

21 March 2017

A California district court has reaffirmed its decision to stay a US$1.5 billion litigation against Chevron over the construction of a jetty for a liquefied natural gas project in Western Australia, pending the outcome of an arbitration.

Canadian patent law not a dramatic change, rules Eli Lilly tribunal

Canadian patent law not a dramatic change, rules Eli Lilly tribunal

21 March 2017

The NAFTA tribunal in Eli Lilly v Canada found that a recently developed "promise utility doctrine" in Canadian jurisprudence on pharmaceutical patents did not represent a dramatic change from previous Canadian law, the newly published award reveals.

Making Musick: lawyer takes on new challenge in LA

Making Musick: lawyer takes on new challenge in LA

21 March 2017

After 12 years with Dutch firms and four with Southern California construction firm Gibbs Giden, arbitration specialist Nathan O'Malley is to launch and lead an international arbitration practice for Musick Peeler & Garrett in Los Angeles.

Ukraine asks to set aside JKX award

Ukraine asks to set aside JKX award

21 March 2017

Ukraine has applied to the English High Court to set aside a US$11.8 million UNCITRAL award made in favour of London-registered oil and gas group JKX – with the state accusing the tribunal of “serious irregularity” when conducting the proceedings.

Dechert scoops Vinson & Elkins partner in Beijing

Dechert scoops Vinson & Elkins partner in Beijing

21 March 2017

After more than 17 years, Vinson's & Elkin's principal international arbitration practitioner in Beijing Nicholas Song has moved to Dechert along with four other members of the firm’s China practice.

Jamaica on brink of passing new law

Jamaica on brink of passing new law

20 March 2017

Jamaica's Senate has been debating an arbitration bill based on the UNCITRAL Model Law that could be law by the end of the week, as a Canadian-funded effort is under way to update legislation in the entire CARICOM region.

Canada defeats NAFTA claim over pharma patents

Canada defeats NAFTA claim over pharma patents

20 March 2017

Canada has defeated a US$374 million NAFTA claim brought by US drugmaker Eli Lilly over the revocation of two drugs patents.